Analgesics in Morocco will deliver steady value growth in 2026, outperforming regional peers by maintaining both volume and value stability amid global price volatility and supply chain disruptions. This resilience is underpinned by the expansion of hospital infrastructure, wider insurance coverage through the AMO and Tadamon schemes, and strict government price controls, all of which contribute to a structural shift towards prescription-led, adherence-based consumption anchored in formal medical practice. The landscape is further shaped by the rapid growth of locally produced generics, accelerating investment in domestic manufacturing, and the regulatory introduction of CBD-based products, creating new avenues for chronic pain management and innovation. For brands seeking to succeed, differentiation through either price leadership or the development of potent, innovative alternatives is crucial, as consumer behaviour shifts towards affordability, safety, and efficacy, and as new entrants leverage local production and evolving preferences for plant-based and non-invasive solutions.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Morocco with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Morocco, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Morocco report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Morocco?
- Which are the leading brands in Analgesics in Morocco?
- How are products distributed in Analgesics in Morocco?
- How has the regulatory and operating environment for Analgesics changed in Morocco?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Hospital expansion and insurance coverage shift pain treatment to prescriptions
Systemic analgesics remain dominant as CBD-based alternatives emerge
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Steady value growth ahead as established brands face price and innovation pressure
Local producers and herbal innovators to reshape pain relief options
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Leading players challenged as generics gain ground
Cooper Pharma’s expansion and M&A set stage for new entrants
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintain dominance through everyday convenience
Glovo’s targeted campaigns expand reach among urban elites
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!